281 assets in Gastric Cancer

Therapeutic assets addressing Gastric Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Elvn-002 Gastric Cancer	Enliven Therapeutics	P1	CC (43)
Epcam Car-T Gastric Cancer	Zhejiang University	P1	CC (43)
Eribulin Gastric Cancer	Enliven Therapeutics	P1	CC (43)
hs-10502 Gastric Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1	CC (43)
hs-20089 Gastric Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1	CC (43)
hs-20093 Gastric Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1	CC (43)
iam1363 Gastric Cancer	Iambic Therapeutics, Inc	P1	CC (43)
Immunoglobulin G1 [351-Alanine,386-Alanine,387-Alanine] Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Imm2902 ?1-Chain), Disulfide With 1-125-Signal Regulatory Protein ? [80-Alanine] (Human Isoform 4 Variant) Fusion Protein With Peptide Linker ((Ggggs)3) Fusion Protein With Human-Mus Musculus Monoclonal Imm2902 ?-Chain, Dimer Gastric Cancer	ImmuneOnco Biopharmaceuticals (Shanghai) Inc.	P1	CC (43)
IPH5301 Gastric Cancer	Institut Paoli-Calmettes	P1	CC (43)
Mvf-Her-2 (266-296) Gastric Cancer	Pravin T.P Kaumaya	P1	CC (43)
p95her2.car-tech2me Gastric Cancer	Vall d'Hebron Institute of Oncology	P1	CC (43)
Xmt-2056 Gastric Cancer	Day One Biopharmaceuticals, Inc.	P1	CC (43)
kd-496 Gastric Cancer	Peking University	P1	CC (42)
Nogapendekin Alfa Inbakicept Gastric Cancer	ImmunityBio, Inc.	P2	CC (42)
[111in]-fpi-1967 Gastric Cancer	Fusion Pharmaceuticals Inc.	P1/2	CC (41)
[18F]FPyQCP Gastric Cancer	Blue Earth Diagnostics	P1/2	CC (41)
[203pb]pb-psv359 Gastric Cancer	Perspective Therapeutics	P1/2	CC (41)
[212pb]pb-psv359 Gastric Cancer	Perspective Therapeutics	P1/2	CC (41)
[225Ac]-FPI-1966 Gastric Cancer	Fusion Pharmaceuticals Inc.	P1/2	CC (41)
64cu-lnth-1363s Gastric Cancer	Lantheus Medical Imaging	P1/2	CC (41)
Amxt1501 Gastric Cancer	Aminex Therapeutics, Inc.	P1/2	CC (41)
Anti-Kras G12V Mtcr Pbl Gastric Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
azd4360 Gastric Cancer	AstraZeneca	P1/2	CC (41)
azd5863 Gastric Cancer	AstraZeneca	P1/2	CC (41)
azd7789 Gastric Cancer	AstraZeneca	P1/2	CC (41)
Balstilimab Gastric Cancer	Rottapharm Biotech	P1/2	CC (41)
bhb810 Gastric Cancer	BigHat Biosciences, Inc.	P1/2	CC (41)
bnt141 Gastric Cancer	BioNTech SE	P1/2	CC (41)
Brodalumab Gastric Cancer	Brian Henick, MD	P1	CC (41)
Camizestrant Gastric Cancer	AstraZeneca	P1/2	CC (41)
Chm-2101 Car-T Cells Gastric Cancer	Chimeric Therapeutics	P1/2	CC (41)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301) Gastric Cancer	Washington University School of Medicine	P1/2	CC (41)
Dexasone Gastric Cancer	Takeda	P1/2	CC (41)
Eflornithine Gastric Cancer	Aminex Therapeutics, Inc.	P1/2	CC (41)
Enzalutamide Gastric Cancer	Cancer Research UK	P1/2	CC (41)
Etx-19477 Gastric Cancer	858 Therapeutics, Inc.	P1/2	CC (41)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-3101 (89.9%) -(Ighd) -Ighj401 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg101 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-1201 (85.3%)-Igkj201 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa Gastric Cancer	Cancer Research UK	P1/2	CC (41)
Gotistobart Gastric Cancer	OncoC4, Inc.	P1/2	CC (41)
her2bbζ/cd19t+ t cells Gastric Cancer	Shanghai Public Health Clinical Center	P1/2	CC (41)
im-1617 Gastric Cancer	Immunome, Inc.	P1	CC (41)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Met (Met Proto-Oncogene, Hepatocyte Growth Factor (Hgf) Receptor, Hgfr, Scatter Factor (Sf) Receptor, Hgf/Sf Receptor, Receptor Tyrosine-Protein Kinase C-Met, Papillary Renal Cell Carcinoma 2, Rccp2)] And Anti-[Homo Sapiens Egfr (Epidermal Growth Factor Receptor, Receptor Tyrosine-Protein Kinase Erbb-1, Erbb1, Her1, Her-1, Erbb)], Homo Sapiens Monoclonal Antibody, Bispecific Gastric Cancer	Merus B.V.	P1/2	CC (41)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Gastric Cancer	Anwaar Saeed	P1/2	CC (41)
Inbrx-106 Gastric Cancer	Inhibrx Biosciences, Inc	P1/2	CC (41)
Mdna11 Gastric Cancer	Medicenna Therapeutics, Inc.	P1/2	CC (41)
mdx2001 Gastric Cancer	ModeX Therapeutics, An OPKO Health Company	P1/2	CC (41)
mt-4561 Gastric Cancer	Tanabe Pharma America, Inc.	P1/2	CC (41)
neo212 Gastric Cancer	Neonc Technologies, Inc.	P1/2	CC (41)
ngm707 Gastric Cancer	NGM Biopharmaceuticals, Inc	P1/2	CC (41)
okn4395 Gastric Cancer	Epkin	P1	CC (41)
Osemitamab Gastric Cancer	Suzhou Transcenta Therapeutics Co., Ltd.	P1/2	CC (41)

Showing 101 to 150 of 281 assets

PreviousPage 3 of 6Next